|
Less than 1% of all breast cancers occur in men, making this a rare disease among that patient population, and most treatment guidelines are based on outcomes and survival rates seen in women with the disease. A recent study published in Cancer investigated the effects of adjuvant chemotherapy for early-stage breast cancer solely among men, with the overall population-based observational results showing the treatment provides benefits in both all-cause and breast cancer — specific mortality for men with invasive stage I to III disease.
|